Latest Share Chat

Physiomics Share News (PYC)

Physiomics Information

Buy PYC Shares
Add PYC to Watchlist
Add PYC to Alert

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.30

Bid: 1.20

Ask: 1.40

Change: -0.20 (-13.33%)

Spread: 0.20 (16.667%)

Open: 1.25

High: 1.30

Low: 1.05

Prev. Close: 1.50

Last checked at -

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Tue, 11th May 2021 17:50

Physiomics PLC - oncology consultant based in Oxford - Awarded its first contract by Zurich-based biopharmaceutical company Numab Therapeutics, which is focused on developing biotherapeutics for chronic inflammation and cancer.

"We are delighted that Numab has selected Physiomics to support them with one of their new programs and look forward to working with their highly talented team," notes Chief Executive Officer Jim Millen.

Current stock price: 5.91 pence

Year-to-date change: down 20%

By Dayo Laniyan; dayolaniyan@alliancenews.com

More News

10 Nov 2023 08:14

Physiomics receives Innovate UK funding grant

(Sharecast News) - Computational biology firm Physiomics said on Friday that it had been awarded a grant by Innovate UK and the Office for Life Sciences as part of the UK Government's Advancing Precision Medicine programme.

28 Sep 2023 12:12

Physiomics shares drop as annual loss widens; revenue falls

(Alliance News) - Physiomics PLC on Thursday kept its outlook upbeat, despite reporting a drop in revenue in what it called a "difficult year."

28 Sep 2023 11:47

LONDON MARKET MIDDAY: Stocks stay downbeat; Digital 9 plunges 32%

(Alliance News) - Stock prices in London were lower at midday on Thursday as elevated oil prices added fuel to inflationary fears and supported the higher for longer narrative around global interest rates.

28 Sep 2023 10:44

AIM WINNERS & LOSERS: Bradda shares surge on updated resource estimate

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

4 Sep 2023 11:21

Physiomics brings in chief operating officer; shares soar

(Alliance News) - Physiomics PLC on Monday named Peter Sargent as its new chief operating officer.

4 Sep 2023 10:27

AIM WINNERS & LOSERS: Physiomics brings in COO; Ergomed receives bid

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

31 Aug 2023 16:50

LONDON MARKET CLOSE: FTSE 100 down amid stubborn US inflation

(Alliance News) - Stock prices in London closed mixed on Thursday, after news that a key US inflation reading came in in line with market expectations.

31 Aug 2023 13:51

UPDATE: Physiomics wins new deal following Merck contract extension

(Alliance News) - Physiomics PLC on Thursday said it won its first contract with an unnamed "UK-based biotech client".

31 Aug 2023 10:41

IN BRIEF: Physiomics to extend anti-cancer regimen work with Merck

Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Has been awarded a further contract by existing client Merck KGaA involving pre-clinical and clinical modelling and simulation of anti-cancer regimens involving combinations of DNA damage and repair agents. Follows on previous Merck-commissioned projects. Expects the contract award to be completed over the next three months.

24 Aug 2023 11:06

ValiRx interim loss widens as costs increase; hails Inaphaea progress

(Alliance News) - ValiRx PLC on Thursday reported an increased half-year loss amid higher costs, as it continued to focus on building its science-focused portfolio.

8 Aug 2023 15:49

Physiomics inks contract extension with Numab Therapeutics

(Sharecast News) - Mathematical modelling company Physiomics, which specialises in the development of oncology drugs and personalised medicine, confirmed a renewed contract with Numab Therapeutics on Tuesday.

8 Aug 2023 10:48

IN BRIEF: Physiomics inks further contract with Numab Therapeutics

Physiomics PLC - London-based mathematical modelling company that supports oncology drug development - Says it has been awarded a further contract by its existing client, Numab Therapeutics. Numab Therapeutics is a Switzerland-based biotechnology firm. The project involves pharmacokinetic-pharmacodynamic modelling in support of one of Numab's clinical programs and follows on from earlier work conducted by Physiomics on the same asset. The project will span two years of the clinical program.

29 Jun 2023 18:55

TRADING UPDATES: Ecofin US Renewables expects to pay reduced dividend

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:

27 Jun 2023 10:49

Physiomics completes GBP335,000 fundraise; announces new retail offer

(Alliance News) - Physiomics PLC on Tuesday said it had completed a fundraise, conditional on admission, of GBP335,000 through a placing with Hybridan LLP, and announced a retail offer from Winterflood retail access platform to raise a maximum of GPB150,000.

27 Jun 2023 10:17

AIM WINNERS & LOSERS: Unbound shares drop as calls off sales process

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Latest Share Chat

Physiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Login to your account

Quickpicks are a member only feature

Login to your account